|
07.04.11
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
04.04.11
|
|
Teva Pharmaceutical Industries neutral
|
Credit Suisse Group
|
|
01.04.11
|
|
Ceragon Networks overweight
|
Barclays Capital
|
|
28.03.11
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
|
28.03.11
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
25.03.11
|
|
Teva Pharmaceutical Industries neutral
|
Credit Suisse Group
|
|
21.03.11
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
22.02.11
|
|
Nice Systems overweight
|
HSBC
|
|
11.02.11
|
|
Radware outperform
|
Oppenheimer & Co. Inc.
|
|
09.02.11
|
|
Teva Pharmaceutical Industries buy
|
UBS AG
|
|
09.02.11
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
|
08.02.11
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
07.02.11
|
|
Teva Pharmaceutical Industries neutral
|
Credit Suisse Group
|
|
04.02.11
|
|
Radware outperform
|
Wedbush Morgan Securities Inc.
|
|
04.02.11
|
|
Radware sector perform
|
RBC Capital Markets
|
|
03.02.11
|
|
Teva Pharmaceutical Industries buy
|
UBS AG
|
|
02.02.11
|
|
Ceragon Networks equal-weight
|
Barclays Capital
|
|
02.02.11
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
|
01.02.11
|
|
Ceragon Networks buy
|
D.A. Davidson & Co.
|
|
26.01.11
|
|
Teva Pharmaceutical Industries neutral
|
Credit Suisse Group
|
|
26.01.11
|
|
Teva Pharmaceutical Industries buy
|
UBS AG
|
|
20.01.11
|
|
Ceragon Networks outperform
|
Oppenheimer & Co. Inc.
|
|
17.01.11
|
|
Teva Pharmaceutical Industries halten
|
Nasd@q Inside
|
|
21.12.10
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
10.12.10
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
|
19.11.10
|
|
Nice Systems overweight
|
HSBC
|
|
29.10.10
|
|
Ceragon Networks outperform
|
Oppenheimer & Co. Inc.
|
|
27.10.10
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
25.10.10
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
|
19.10.10
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
11.10.10
|
|
Teva Pharmaceutical Industries neutral
|
Nasd@q Inside
|
|
27.09.10
|
|
Radware perform
|
Oppenheimer & Co. Inc.
|
|
10.09.10
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
|
10.09.10
|
|
Teva Pharmaceutical Industries outperform
|
Oppenheimer & Co. Inc.
|
|
19.08.10
|
|
Teva Pharmaceutical Industries buy
|
Citigroup Corp.
|
|
03.08.10
|
|
Teva Pharmaceutical Industries overweight
|
Barclays Capital
|
|
02.08.10
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
|
27.07.10
|
|
Ceragon Networks sector perform
|
RBC Capital Markets
|
|
26.07.10
|
|
Teva Pharmaceutical Industries outperform
|
RBC Capital Markets
|
|
20.07.10
|
|
Teva Pharmaceutical Industries buy
|
Société Générale Group S.A. (SG)
|
anmelden
